Intelligence · Clinical Development
Pipeline search results
Programs matching “letrozole” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 11 pipeline programs matching "letrozole" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Letrozole
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
United Therapeutics Europe Ltd
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
1 trial -
FULVESTRANT, LETROZOLE
Pfizer Australia Pty Ltd
HR-positive HER2-negative metastatic/advanced BC
1 trial -
LETROZOLE, FULVESTRANT
Pfizer Australia Pty Ltd
Part 2A, 2B, 2C & 2E HR-positive /HER2-negative breast cancer, Part 1F Prostate cancer, Part 2D mCRPC, Part 1A/Part 1D/Part1E Breast cancer, NSCLC, prostate, CRC, liposarcoma, or tumors with previously confirmed CDK4 or CCND1 amplification., Part 1B &1C HR-positive/HER2-negative breast cancer
1 trial -
Letrozole
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uterine Cervical Neoplasms
1 trial -
Letrozole
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Letrozole
United Therapeutics Europe Ltd
Lymphangioleiomyomatosis
1 trial -
Letrozole
Context Therapeutics
Metastatic Breast Cancer
1 trial -
Letrozole
The First People's Hospital of Lianyungang
Intrauterine Insemination
1 trial -
Letrozole
International Peace Maternity and Child Health Hospital
Letrozole
1 trial -
Letrozole -Berberine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polycystic Ovary Syndrome
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.